We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RSKD:NYSERiskified Ltd. Analysis

Data as of 2026-04-29 - not real-time

$4.46

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Riskified Ltd. (RSKD) trades at $4.46, comfortably above its 20‑day ($4.27) and 50‑day ($4.30) simple moving averages but still below the 200‑day average ($4.67), indicating short‑term momentum within a longer‑term bearish backdrop. Technical indicators are supportive: the MACD line sits above its signal (bullish) and the RSI at 57 suggests the stock is not overbought, while volume is on an upward trend. Fundamentally, the company posted a revenue growth of 6.2% and a solid gross margin of 52%, yet it remains loss‑making with a –8% profit margin and a trailing PE of zero. Recent earnings beat expectations (EPS $0.12 vs $0.10) and a new share‑repurchase program signal confidence from management, while the partnership with Outpayce adds an AI‑driven fraud solution to its pipeline.
The discounted cash‑flow model places fair value at $7.08, implying roughly 24% upside from current levels, and the forward PE of 12.9 is well below the industry average of 37.5, supporting an undervalued stance. Strong free cash flow ($44.4M) and a cash‑heavy balance sheet (cash $298M vs debt $25M) mitigate liquidity concerns, though the company’s high volatility (38% 30‑day) and negative earnings underscore the need for continued operational improvement.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and rising volume
  • Immediate upside to DCF target
  • Recent earnings beat and share repurchase announcement

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to forward PE and industry average
  • Revenue growth and new AI partnership expanding TAM
  • Strong cash generation despite current losses

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential for sustained profitability as margins improve
  • Exposure to global e‑commerce fraud market offsets sector risk
  • Need to convert cash flow advantage into consistent earnings

Key Metrics & Analysis

Financial Health

Revenue Growth6.20%
Profit Margin-8.00%
P/E Ratio12.9
ROE-8.14%
ROA-4.65%
Debt/Equity8.49
P/B Ratio2.2
Op. Cash Flow$33.9M
Free Cash Flow$44.4M
Industry P/E37.5

Technical Analysis

TrendBearish
RSI57.1
Support$3.85
Resistance$4.73
MA 20$4.27
MA 50$4.30
MA 200$4.67
MACDBullish
VolumeIncreasing
Fear & Greed Index89.59

Valuation

Fair Value$7.08
Target Price$5.55
Upside/Downside24.44%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.03
Volatility38.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.